drugset / Trial / NCT01141127

Tranexamic Acid (TXA) in Pediatric Cardiac Surgery

NCT01141127

Phase 2 Completed 18 enrolled Centre Chirurgical Marie Lannelongue
RandomizedParallel-groupSingle-blindSupportive care

Summary

The purpose of this study is to determine tranexamic acid plasma levels in children undergoing cardiac surgery at risk of bleeding and to compare two dosing regimens.

Timeline

Start
2010-06
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 mg/kg Intravenous
Subject Tranexamic Acid Small molecule 10 mg/kg Intravenous

Indications